VUF11207 fumarate

• CAT Number: I017904
• CAS Number: 1785665-61-3
• Molecular Formula: C31H39FN2O8
• Molecular Weight: 586.65
• Purity: ≥95%
• Synonyms: (E)-but-2-enedioic acid;N-[(E)-3-(2-fluorophenyl)-2-methylprop-2-enyl]-3,4,5-trimethoxy-N-[2-(1-methylpyrrolidin-2-yl)ethyl]benzamide
• InChI: InChI=1S/C27H35FN2O4.C4H4O4/c1-19(15-20-9-6-7-11-23(20)28)18-30(14-12-22-10-8-13-29(22)2)27(31)21-16-24(32-3)26(34-5)25(17-21)33-4;5-3(6)1-2-4(7)8/h6-7,9,11,15-17,22H,8,10,12-14,18H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b19-15+;2-1+
• InChIKey: MTPOECCHJLVVGO-FDULSSLPSA-N
• SMILES: C/C(=C\C1=CC=CC=C1F)/CN(CCC2CCCN2C)C(=O)C3=CC(=C(C(=C3)OC)OC)OC.C(=C/C(=O)O)\C(=O)O

VUF11207 fumarate（Cat No.:I017904）is a selective small-molecule agonist of G protein-coupled receptor 55 (GPR55), an orphan receptor implicated in diverse physiological and pathological processes. By activating GPR55, VUF11207 modulates signaling pathways associated with pain perception, inflammation, cancer progression, and metabolic regulation. The fumarate salt enhances stability and solubility for laboratory use, facilitating in vitro and in vivo studies. As a pharmacological probe, VUF11207 fumarate is valuable for dissecting GPR55’s biological roles and therapeutic potential, supporting research in immunology, oncology, neurology, and metabolic disease fields.